Keystone Clinical Studies (KCS) is an independent clinical trial site focused on drug development for neuropsychiatric disorders. KCS is highly regarded in the field for our data quality and excellent patient care. In the last 20 years, KCS has participated in over 130 FDA supervised clinical trials that led to the approval of medications for 10 different conditions.
Based in Plymouth Meeting, PA, Keystone Clinical Studies is part of national and global multi-centric clinical trials, and is one of very few sites in the Greater Philadelphia area. KCS is now working on a very exciting range of medications, targeted at different parts of the pathological cascade in Alzheimer’s Disease.
These include:
- A pivotal NIH study for Alzheimer’s prevention in preclinical/asymptomatic individuals (www.aheadstudy.org)
- Monoclonal antibody studies targeting amyloid (plaques) in Early Alzheimer’s Disease
- Monoclonal antibody studies targeting tau (tangles) in Early Alzheimer’s Disease
- Medications that promote neuro-regeneration in Alzheimer’s dementia
- Medications targeted against neuroinflammation
Job Summary:
This is a full-time position offering a competitive salary based on the candidate’s education and experience. Health care coverage and PTO will be provided. Productivity bonuses will given based on performance.
The Clinical Research Coordinator position has two roles:
Research Coordinator: Maintain 3-5 clinical trials as the primary coordinator, leading the recruitment, visit management, patient charting, query resolution, and regulatory document maintenance for each trial under FDA regulations and utilizing principles of Good Clinical Practices (GCP).
Rater: Conduct structured clinical and psychometric assessments with patients and caregivers to evaluate the severity of a patient’s illness and level of functioning.
No prior clinical trial experience is required. All job-related training will be provided in the first 3 month probationary period, after which time, the person will be expected to get certification and approval from agencies that supervise the trial site and trial processes.